HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hankun Li Selected Research

N- (3- (4- chlorophenyl)- 2- (3- cyanophenyl)- 1- methylpropyl)- 2- methyl- 2- ((5- (trifluoromethyl)pyridin- 2- yl)oxy)propanamide

12/2010Development of a population pharmacokinetic model for taranabant, a cannibinoid-1 receptor inverse agonist.
10/2010Metabolism and excretion of [14C]taranabant, a cannabinoid-1 inverse agonist, in humans.
6/2008Multiple-dose pharmacokinetics, pharmacodynamics, and safety of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, in healthy male volunteers.
4/2008Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, for the treatment of obesity: results from a double-blind, placebo-controlled, single oral dose study in healthy volunteers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hankun Li Research Topics

Disease

6Neoplasms (Cancer)
01/2019 - 01/2015
4Obesity
12/2010 - 04/2008
3Carcinogenesis
01/2019 - 01/2017
1Brain Diseases (Brain Disorder)
01/2020
1Acute-Phase Reaction
01/2019
1Infections
10/2012
1Nausea
04/2008
1Vomiting
04/2008
1Headache (Headaches)
04/2008
1Dizziness (Lightheadedness)
04/2008
1Hiccup (Hiccups)
04/2008
1Abdominal Pain (Pain, Abdominal)
04/2008

Drug/Important Bio-Agent (IBA)

4N- (3- (4- chlorophenyl)- 2- (3- cyanophenyl)- 1- methylpropyl)- 2- methyl- 2- ((5- (trifluoromethyl)pyridin- 2- yl)oxy)propanamideIBA
12/2010 - 04/2008
2RNA (Ribonucleic Acid)IBA
01/2019 - 01/2015
2AndrogensIBA
01/2019 - 01/2017
2Estrogens (Estrogen)FDA Link
01/2019 - 01/2017
2Pharmaceutical PreparationsIBA
01/2017 - 04/2008
2CannabinoidsIBA
10/2010 - 04/2008
1Uridine Diphosphate Glucose (UDP Glucose)IBA
01/2020
1Androgen Receptors (Androgen Receptor)IBA
01/2019
1Gonadal Steroid Hormones (Sex Hormones)IBA
01/2019
1ThrombinFDA Link
01/2019
1cyclopamineIBA
01/2017
1SU 5402 (SU5402)IBA
01/2017
1orantinib (SU6668)IBA
01/2017
1GANT 61IBA
01/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017
1CateninsIBA
01/2017
1Protein Isoforms (Isoforms)IBA
01/2015
1ML-265IBA
01/2015
1RNA Splicing FactorsIBA
01/2015
1Human immunodeficiency virus 1 p31 integrase proteinIBA
10/2012